CSLLY News and Press, CSL Ltd. ADR From 09/26/25

CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy Canada NewsWire FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss ST. GALLEN, Switzerland ...

2025-09-17 15:41:16 ET More on Pfizer, Moderna, etc. Pfizer: Cheap Doesn't Mean Good Why I Sold Pfizer To Buy Novo Nordisk Pfizer's Comeback Accelerates U.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meeting Former CDC Di...

PHILADELPHIA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Mark Cuban Foundation, in partnership with CSL, will host a no-cost Artificial Intelligence Bootcamp for high school students in Philadelphia this fall. The program is open to students in grades 9–12 and will take place over three consec...

2025-08-12 14:34:19 ET When I last wrote about the biotech stock Vertex Pharmaceuticals (NASDAQ: VRTX ) a month ago, its price has dropped by ~20%. This is exactly the extent of correctionI had forecast for it, but with a difference. I had expected the decline to play out over the r...

Reeds Inc. (REED) is expected to report $-0.04 for Q2 2025 Jerash Holdings (US) Inc. (JRSH) is expected to report for Q1 2026 Churchill Capital Corp IX (CCIX) is expected to report for quarter end 2025-06-30 Verde Clean Fuels Inc. (VGAS) is expected to report for Q2 2025 Mobile In...

CSL Ltd. ADR (CSLLY) is expected to report for Q4 2025

Health Canada Has Authorized CSL's ANDEMBRY® (garadacimab) as Once-Monthly Treatment for Hereditary Angioedema (HAE) Canada NewsWire ANDEMBRY is the first and only once-monthly treatment targeting factor XIIa to prevent recurrent attacks in people with HAE The authori...

2025-08-06 07:05:31 ET More on Moderna, Pfizer, etc. Pfizer Inc. (PFE) Q2 2025 Earnings Call Transcript Wall Street Lunch: Trump Threatens 250% Tariff On Pharma Pfizer Q2 Earnings Review: Upside At Last As CEO Prepares For Trump Policy Battle Pfizer raises 20...

2025-07-23 11:46:19 ET More on GSK, Sanofi, etc. Sanofi: A Solid EU Contrarian Play AstraZeneca: Just What The Doctor Ordered GSK's Specialty Medicines Surge - Still Looks Undervalued In 2025 ANI Pharma drops as clinical trial for eye implant fails against Re...

2025-07-15 10:34:54 ET More on CSL WHO says thimerosal in vaccines not harmful CSL to replace Bavarian Nordic in Valneva’s vaccine deal for Germany Seeking Alpha’s Quant Rating on CSL  Historical earnings data for CSL  ...